Health Care Barriers Contribute to Delays in Follow-Up Screening for Women With Cancer
the ONA take:
Researchers performed secondary analyses of data from the intervention arms of the Patient Navigation Research Program to gain a better understanding of the association between barriers to care and clinical outcomes within patient navigation programs.
The data included navigated participants with abnormal breast and cervical cancer screening test results from 2007 to 2010.
The researchers considered the number of unique barriers (0, 1, 2, ≥3) documented during patient navigation encounters and the presence of socio-legal barriers originating from social policy (yes/no).
Approximately 75% of 2,600 breast screening participants and more than one-half of 1,387 cervical screening participants had barriers to care documented.
Any number of barriers was associated with less timely resolution among breast cancer participants compared with those who had no barriers documented; however, only the presence of two or more barriers was associated with less timely resolution among cervical screening participants.
The study findings demonstrated that barriers to care resulted in less timely resolution of abnormal screening results among navigated women.
The researchers conclude further innovations are needed to improve the impact of patient navigation programs nationwide.
A better understanding of the association between barriers to care and clinical outcomes within patient navigation programs.
- Cholesterol-Lowering Drugs May Prevent Breast Cancer Recurrence
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Idelalisib Increases Progression-Free Survival in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Immunotherapy and the Future of Prostate Cancer Treatment
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Nut Consumption Inversely Associated With Lung Cancer Risk
- Use of Checkpoint Inhibitors in Urothelial Carcinoma
- Chemo + Radiotherapy Efficacious in Muscle-invasive Bladder Cancer
- Elderly with NSCLC Can Tolerate Aggressive Radiation Therapy Treatments
- Colorectal Cancer Risk Higher With Poor Metabolic Health vs Increased Weight
- Best Approach to Infection and Tumor Treatment: Contain or Eliminate?
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|